Podcasts about baylor college

When bad journalism and moneyed interests collide, science suffers. Peter J. Hotez is dean of the National School of Tropical Medicine and professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine – and he played a key role in developing the Covid-19 vaccine. He joins host Krys Boyd to discuss how anti-science factions have hijacked the conversation and his many failed attempts to HHS Secretary Robert F. Kennedy Jr. onboard with vaccines. His book, written with Michael E. Mann, is “Science Under Siege: How to Fight the Five Most Powerful Forces that Threaten Our World.” Learn about your ad choices: dovetail.prx.org/ad-choices

Send us a textAging, tissue repair, and the longevity benefits of psilocin.Episode Summary: Dr. Louise Hecker discusses her research on tissue repair and regeneration, explaining how fibroblasts drive wound healing by forming scar tissue but fail to resolve properly with age, leading to fibrotic diseases like pulmonary fibrosis and liver cirrhosis; they discuss aging hallmarks such as oxidative stress and telomere shortening, and highlight Hecker's study showing psilocybin's active metabolite, psilocin, extends cellular lifespan in lab cultures by reducing oxidants and preserving telomeres, while monthly doses in aged mice improved appearance and survival rates.About the guest: Louise Hecker, PhD is an Associate Professor of Medicine at Baylor College of Medicine, specializing in repair and regeneration processes, particularly in aging and fibrotic diseases.Discussion Points:Fibroblasts are dormant cells that activate during injury to pull wounds closed and form scars, then de-differentiate or die; aging impairs this, causing persistent scarring and disease.Aging reduces the body's regenerative capacity; different organs vary in repair efficiency, with skin healing better than heart tissue.Oxidative stress, like "rust" in the body, accumulates with age due to imbalanced reactive oxygen species production and antioxidant defenses, contributing to cellular damage.Telomeres act as protective DNA caps that shorten with cell divisions, serving as a hallmark of biological aging; sirtuins are master regulators influencing aging processes.Hecker's in vitro study showed psilocin dose-dependently extended fibroblast lifespan by 29-50%, lowering oxidative stress below young cell levels and preserving telomeres.In aged mice (equivalent to 60-65 human years), monthly high-dose psilocybin (15 mg/kg) led to healthier appearance, regrown fur, and 80% survival when controls reached 50% mortality after 10 months.Psilocybin's effects may stem from serotonin receptors expressed in many cell types beyond the brain, suggesting broader anti-aging potential; future work explores mechanisms, optimal dosing, and applications for age-related diseases.Fungi like magic mushrooms represent an under-explored "kingdom" for medicine, with psilocybin's durable effects hinting at systemic impacts on aging.Reference Paper:Study: Psilocybin treatment extends cellular lifespan and improves survival of aged miceRelated content:Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

On Monday's show: We preview this week's vote on the Harris County budget. The budget process this year has often been contentious as tensions rise over funding cuts.Also this hour: Dr. Peter Hotez of Baylor College of Medicine discusses his book, Science Under Siege, which examines growing opposition to science and the threat it poses.Then, veterinarian Dr. Lori Teller answers listeners' questions about their pets.And Jeff Balke previews a season-defining week ahead for the Astros and the Monday Night Football matchup between the Texans and the Buccaneers. Watch

Climatologist Michael Mann and vaccine expert Peter Hotez say we're in an “antiscience superstorm.” It's a movement that has upended federal health agencies, defunded research and weaponized social media and AI to advance its agenda. And now, some of the nation's most vocal antiscience figures are in major positions of power. We talk to Hotez and Mann about their daily battles against disinformation, their personal toll and what we can all do to counter the antiscience threat. Their new book is “Science Under Siege.” Guests: Peter J. Hotez, professor and dean of the National School of Tropical Medicine, Baylor College of Medicine; co-director of the Center for Vaccine Development, Texas Children's Hospital Michael E. Mann, professor of earth and environmental science, University of Pennsylvania; director, Penn Center for Science, Sustainability and the Media Learn more about your ad choices. Visit megaphone.fm/adchoices

In this special episode, host Jeremy Schrand sits down with Jill Brinck, Executive Director of CancerFree KIDS, and Dr. Genevieve Kendall, a CancerFree KIDS grant recipient and pediatric cancer researcher at Baylor College of Medicine. Together, they explore the power of early-stage research funding, the challenges and breakthroughs in treating childhood cancers, and the inspiring mission behind CancerFree KIDS. Dr. Kendall shares insights into her lab's work on fusion-driven rhabdomyosarcoma and how innovative models like transgenic zebrafish are helping uncover new therapeutic targets. Whether you're a parent, a scientist, or someone passionate about making a difference, this episode offers a compelling look at how collaboration and curiosity are driving real change in pediatric oncology. Learn more - CancerFree KIDS home page Learn more about Dr Kendall's research - Kendall Lab | Nationwide Children's Hospital Learn more about CTI - CTI - CRO Specializing In Clinical Research And Consulting  02:03 Jill Brink shares her personal and professional journey that led her to become Executive Director of CancerFree KIDS.  04:02 Why funding early-stage, high-risk research is essential for pediatric cancer, highlighting the lack of profitability and federal support in this space. 05:46 Securing funding for early-stage research presents major challenges, including the need for collaboration between scientists and business leaders.  07:06 How CancerFree KIDS selects research projects, outlining the role of their Scientific Advisory Council and the grant scoring process. 09:26 Success stories driven by CancerFree KIDS funding, including early support for clinical trials and advancements in flash proton therapy. 11:22 Dr. Genevieve Kendall explains the nature of fusion-driven rhabdomyosarcoma and why its aggressive behavior and lack of targeted therapies make it difficult to treat. 13:51 How the CancerFree KIDS grant supported a new partnership and provided seed funding to test a promising research idea. 14:50 The significance of identifying HAS3 as a novel target and how it opens new possibilities for treating rhabdomyosarcoma. 16:35 Dr. Kendall describes the role of transgenic zebrafish in her research and how they help uncover therapeutic targets through comparative oncology. 19:33 Both guests share what excites them most about the future of pediatric cancer research, including innovations in CRISPR and immunotherapy. 22:32 How CancerFree KIDS measures the long-term impact of its grants, citing follow-up funding, startup companies, and FDA projects. 24:19 Jill highlights impactful partnerships and community initiatives, such as Jersey Mike's Day of Giving and the 100-Mile Challenge. 26:15 Details about the 100-Mile Challenge, including its structure and supporting events throughout September. 27:51 How CancerFree KIDS engages with families affected by cancer, ranging from support programs to events that honor children and their journeys. 29:51 The future direction of CancerFree KIDS, including expansion, collaboration, and advocacy efforts with the state of Ohio. 

Dr. Carole Keim welcomes pediatric dermatologist Dr. Teresa Wright, MD, to the podcast to talk about baby skin care, birthmarks, eczema, and anything to watch out for with a baby's skin that could potentially be dangerous. Dr. Wright works at Le Bonheur Children's Hospital in Memphis, Tennessee and is also faculty at the University of Tennessee Medical Center. She shares her journey into pediatric dermatology and explores all manner of common skin concerns, conditions, and questions regarding infants and their skin care with Dr. Keim, based on a wealth of experience and knowledge. Dr. Keim and Dr. Wright open by addressing the little pink or red spots in the middle of a newborn's forehead that are sometimes called angel kisses. The medical term is nevus simplex, and Dr. Wright assures listeners that they're nothing to worry about and will fade over time. They discuss types of newborn skin rashes, such as transient neonatal pustular melanosis, which are normal, before addressing conditions that might need a pediatrician's attention. Baby moles are explained in detail, atopic dermatitis or eczema is described, and Dr. Wright offers insight on how to mitigate or improve child skin dryness, along with tips on avoiding exposure to known irritants and allergens. This episode is full of facts and advice on infant skin, offering a practical guide to what is normal and what might need additional attention.Dr. Teresa Wright, MD:Dr. Wright attended medical school at the University of Massachusetts in Worcester, Massachusetts. She went on to complete a residency in pediatrics at the University of Massachusetts Medical Center. Subsequently, she completed a dermatology residency at the University of Kansas Medical Center and a fellowship in pediatric dermatology at Children's Mercy Hospitals and Clinics in Kansas City, Missouri. She joined the dermatology faculty at Baylor College of Medicine and Texas Children's Hospital (TCH) in January of 2009. In January of 2012, she was promoted to Section Chief of Pediatric Dermatology at TCH. She also served as Co-Director of the Vascular Anomalies Program at TCH from October 2011 through March of 2015. In July of 2015, she returned to her hometown of Memphis, TN to join the dermatology faculty at the University of Tennessee and establish a pediatric dermatology division at LeBonheur Children's Hospital. She has special interests and expertise in the diagnosis and management of hemangiomas and other vascular lesions, as well as pigmented lesions and pediatric melanoma. She is board-certified in pediatric dermatology, dermatology, and pediatrics. She is a member of the American Academy of Dermatology, the American Academy of Pediatrics, and the Society for Pediatric Dermatology.Dr. Wright has special interests and expertise in the diagnosis and management of hemangiomas and other vascular lesions, as well as pigmented lesions and pediatric melanoma.__ Resources discussed in this episode:The Holistic Mamas Handbook is available on AmazonThe Baby Manual is also available on Amazon__Contact Dr. Carole Keim, MDlinktree | tiktok | instagramContact Dr. Teresa Wright, MDwebsite | linkedin

Peter Hotez, MD, PhD, founding dean of the National School of Tropical Medicine, codirector of the Texas Children's Center for Vaccine Development, and professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine and Michael E. Mann, presidential distinguished professor and director of the Center for Science, Sustainability and the Media at the University of Pennsylvania and author of several books and co-author and, together, co-authors of Science Under Siege: How to Fight the Five Most Powerful Forces that Threaten Our World (PublicAffairs, 2025), talk about the specific groups promoting anti-science and how they make fighting the global threats of disease and climate change harder. 

Send us a textIn this episode, we welcome Dr. Bianca Edison, a pediatric sports medicine and orthopedic physician, to discuss the critical issues surrounding youth sports. Dr. Edison shares her journey into sports medicine and emphasizes the importance of balancing athletic activities for young athletes. The discussion covers overtraining, the significance of rest and recovery, the impact of burnout, and practical advice for preventing common sports injuries in children. We also dive into the importance of sleep, quality nutrition, and healthy exercise habits. This episode offers valuable insights for parents, coaches, and young athletes aiming for long-term health and enjoyment in sports. Dr. Bianca Edison is a pediatric sports medicine and orthopedic physician at Children's Hospital Los Angeles and Clinical Associate Professor of Orthopedic Surgery at USC's Keck School of Medicine. She received her MD from Baylor College of Medicine, completed pediatrics internship and residency at UCLA (where she served as Chief Resident), and pursued a sports medicine fellowship at CHLA. Bianca's clinical work focuses on overuse injuries, injury prevention, dance medicine, and concussion—helping young athletes stay healthy and love movement for life.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagno...

As part of the US HUPO sponsored "Alt Proteomics" series highlighting alternative proteomics things, Ben and Ben sit down to talk with Dr. Olga Dudchenko, Baylor College of Medicine.keywords: structural genomics; Hi-C; DNA Zoo

Dr. Toni Engram is a biological dentist, integrative health coach, and owner of Flourish Dental Boutique in Richardson, TX. A fter her own personal health struggles with an autoimmune disease, Dr. Engram shifted her practice philosophy to focus on whole-body health, and the prevention and safer treatment of oral disease. She has degrees from Texas Christian University and Baylor College of Dentistry. Dr. Engram is a member of the IAOMT (International Academy of Oral Medicine and Toxicology) and the IABDM (International Academy for Biological Dentistry and Medicine). She is SMART certified in safe amalgam removal technique, accredited through the IAOMT, and is a TBI Ambassador through The Breathe Institute. She is also a certified Integrative Health Coach through the Institute of Integrative Nutrition. In this episode, Dr. Engram talks about the difference in approaches in traditional dentistry vs. biological dentistry, and how to eat and supplement to optimize your oral health!     RESOURCES: Learn more about Dr. Engram here: http://www.flourish.dental/ Instagram: @drtoniengram Get 15% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 0:00 Intro 3:30 How biological dentistry is different 8:30 Fluoride free toothpaste 12:15 Mercury amalgams 18:50 Dr. Engram's personal healing journey 24:00 Link between periodontal and heart diseases 30:35 How to fight decay 36:10 Weston A. Price's dental research in native communities 44:00 Insurance issues   WORK WITH ME: Are You Looking for Help on Your Wellness Journey? Here's how I can help you: TRY COACH TARA APP FOR FREE: http://taragarrison.com/app LEVEL UP PROGRAM: http://taragarrison.com/level-up INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the ‘Ratings & Reviews' section. Tap ‘Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A 42-year-old man who has lived most of his life with type 1 diabetes has become the first human to receive a transplant of genetically modified insulin-producing cells. This marks the first pancreatic cell transplant in a human to sidestep the need for immunosuppressant drugs. “This is the most exciting moment of my scientific career,” says cell biologist Per-Ola Carlsson of Uppsala University in Sweden, who helped develop the procedure. The new treatment, he says, “opens the future possibility of treating not only diabetes but other autoimmune diseases.” This procedure uses the gene editing technique, CRISPR, to discourage the auto immune attack on the donor cells. Before the transplant, the participant had no measurable naturally produced insulin and was receiving daily doses of the hormone. But within four to 12 weeks following the transplant, his levels rose slightly on their own after meals—showing that the new beta cells were releasing some insulin in response to glucose. even though the new study is promising, it involved just one participant and is therefore preliminary. And longer-term monitoring is needed to confirm the therapy's safety before it can be offered to more people. She also notes that the injected cells produced only 7 percent of the insulin needed for a person to be fully independent of additional medication. The researchers supplied the recipient with insulin doses to maintain healthy blood sugar levels. While Herold thinks it's still too early to consider this approach for a cure, “these options are now here to change the disease in ways that have never been possible before,” he says. “There's tremendous hope.” https://www.scientificamerican.com/article/type-1-diabetes-patients-insulin-production-restored-with-new-cell/ XX   This one is interesting… a recent study shows that children of mothers with gestational diabetes or fathers with type 2 diabetes have higher chances of developing type 1 diabetes than kids whose parents do not have any type of diabetes. Specifically, the study found that children whose mothers had gestational diabetes during pregnancy were 94% more likely to develop type 1 diabetes compared to children of mothers without diabetes. Similarly, having a father with type 2 diabetes was linked to a 77% higher risk. The study also suggests a possible link between maternal type 2 diabetes and type 1 diabetes in children, although more data are needed to confirm whether the risk is real.   "What is interesting is that type 1 diabetes is a disease of lack of the hormone insulin while gestational diabetes and type 2 diabetes stem mostly from the body's resistance to the hormone. What may be happening is that genes, environments and behaviors that create insulin resistance may also, in some cases, trigger the immune reactions that lead to type 1 diabetes," adds Dr. Dasgupta. A 2019 meta-analysis by researchers at Soochow University in China found that gestational diabetes was linked to a 66% higher risk of type 1 diabetes in children. This new study, which includes more than twice as many studies, offers a robust synthesis of current evidence and shows the risk is even greater than previously estimated. It is also the first meta-analysis to examine the link between paternal type 2 diabetes and type 1 diabetes in offspring. "Several mechanisms may be at play. Families often share lifestyle and eating habits, which can raise the likelihood that children will be affected. But beyond that, high blood sugar levels may also cause biological changes in parents that could increase their children's risk of developing type 1 diabetes," explains Laura Rendon, co-first author of the study, who completed an MSc in experimental medicine at The Institute and, as someone living with type 1 diabetes herself, finds deep personal meaning in conducting this research. For instance, the authors suggest that high blood sugar during pregnancy may stress the fetus's insulin-producing beta cells, reducing their number at birth or making them more vulnerable to damage later in life. It may also trigger epigenetic changes—modifications to proteins and molecules attached to DNA—that increase the risk. Likewise, high blood sugar in fathers with type 2 diabetes may cause epigenetic changes in their sperm, potentially influencing their child's risk of developing type 1 diabetes. https://medicalxpress.com/news/2025-08-diabetes-children-linked-parents.html XX Can a CGM help you lose weight? The company Signos is banking on it – the just got FDA approval for their system, which uses the over the counter Dexcom Stelo. The claim here is that the system will help track how food choices, activity, stress and sleep can all affect metabolism. Signos also works in partnership with the digital nutrition counseling startup Nourish. It currently offers a quarterly subscription plan, including six CGM sensors, for $139 per month. And they tell you don't take any medical actions based on the app's output without consulting a physician. https://www.fiercebiotech.com/medtech/fda-clears-signos-over-counter-cgm-powered-weight-loss-app XX Good news for T1D1, a free mobile app that helps people calculate insulin doses, track daily data, and share insights with healthcare providers. After being pulled off the market with similar apps a few years ago, it's now back and FDA approved. Drew Mendelow created the app after his diagnosis at age 13. He came on the show last year and I'll link his story up in the show notes. Diabetes Center Berne provided the initial funding to support the T1D1 efforts to redesign the app per FDA standards.  Comerge AG , the registered manufacturer, enlisted a team of software engineers, regulatory experts, and design professionals to ensure T1D1 was FDA-ready. Dexcom graciously conducted the Human Factors study to ensure safety and accuracy.  ​ ​T1D1 is now FDA-cleared as a Class II medical device and is the first over-the-counter insulin calculator cleared for individuals aged 2 and older. T1D1 is expected to be live in the AppStore and Google Play Store by October 2025. https://diabetes-connections.com/the-fda-took-down-this-teens-free-bolus-calculator-he-needs-your-help-to-bring-it-back/ XX Metformin has been the standard treatment for type 2 diabetes for more than six decades, yet scientists still do not fully understand how it works. A team from Baylor College of Medicine, working with international collaborators, has now identified an unexpected factor in its effectiveness: the brain. Their findings reveal a brain pathway involved in metformin's glucose-lowering action, pointing to new strategies for treating diabetes with greater precision. The study was published in Science Advances. The researchers concentrated on a small protein called Rap1, located in a region of the brain known as the ventromedial hypothalamus (VMH). They discovered that metformin's ability to lower blood sugar at clinically relevant doses depends on suppressing Rap1 activity in this brain area.   “This discovery changes how we think about metformin,” Fukuda said. “It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”     https://scitechdaily.com/after-60-years-scientists-uncover-hidden-brain-pathway-behind-diabetes-drug-metformin/   XX Looks like GLP-1 pills are moving ahead. Lilly says it's version helped overweight adults with type 2 lose 10% of their body weights and lower A1C. Just two weeks ago, we were talking about how the same drug in people without diabetes had less than the stellar expected results. Orforglipron is a small-molecule pill that is easier to manufacture and package than wildly popular injectable drugs for obesity, such as Lilly's Zepbound and Novo Nordisk's NOVOb.CO rival treatment Wegovy, which are peptide mimics of the appetite-controlling GLP-1 hormone. In the 72-week study of more than 1,600 overweight or obese adults with type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds (10.43 kg), versus 2.2% for those who received a placebo, achieving the main goal of the trial. Patients on the lowest 6 mg dose of the Lilly drug lost 5.5% of their weight. https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/ XX     An intervention that combined a low-calorie Mediterranean diet and exercise led to less diabetes incidence in older adults. Men had a greater diabetes risk reduction with the intervention than women. The study was based in Spain, and the diet may not be as easy to adhere to in the U.S. Among nearly 5,000 adults with metabolic syndrome and overweight or obesity in the PREDIMED-Plus trial, those who followed this intervention had a 31% lower risk for type 2 diabetes over 6 years relative to those who received only ad libitum Mediterranean diet advice (aHR 0.69, 95% CI 0.59-0.82). the Mediterranean diet focuses on high intake of plant-based foods, moderate consumption of fish, poultry, and dairy with optional red wine, and low intake of red meats, sweets, and sugar-sweetened beverages. Common foods featured in the diet include extra-virgin olive oil, fruits, vegetables, legumes, nuts, and whole grains. However, Sharon Herring, MD, MPH, and Gina Tripicchio, PhD, MSEd, both of Temple University in Philadelphia, pointed out that this study was conducted solely in Spain, and sticking to this type of diet may be more challenging in countries like the U.S.   "Participants in the study received extra-virgin olive oil to support adherence and retention; in the United States, prices of extra-virgin olive oil have nearly doubled since 2021 due to a combination of factors including climate change, rising production costs, supply chain disruptions, and now tariffs," they noted in an accompanying editorial. "[T]he large number of dietitian contacts during the study may prove difficult to scale broadly in the United States given challenges with health care access and reimbursement for prevention services."         https://www.medpagetoday.com/primarycare/diabetes/117151 XX A group of Canadian researchers has identified an unexpected way to lower blood sugar and protect the liver: by capturing a little-known fuel produced by gut bacteria before it enters the body and causes harm. The findings, published in Cell Metabolism, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Scientists from McMaster University, Université Laval, and the University of Ottawa discovered that a molecule generated by gut microbes can cross into the bloodstream, where it drives the liver to overproduce glucose and fat. By designing a method to trap this molecule in the gut before it reaches circulation, they achieved striking improvements in blood sugar regulation and fatty liver disease in obese mice. https://scitechdaily.com/scientists-discover-a-surprising-new-way-to-fight-diabetes/ XX Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego, according to the San Diego Union Tribune. The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing. The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google's corporate parent. Verily's work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.” A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.” https://timesofsandiego.com/business/2025/08/27/report-life-sciences-firm-dexcom-lay-off-200-san-diego-workers/ XX Front office changes at Insulet. Eric Benjamin, former chief product and customer experience officer, will take the role of chief operating officer, effective immediately. Manoj Raghunandanan Mu-NOHJ Rug-a-nun-da-nun to the position of chief growth officer, leading Insulet's new growth organization. The appointments are some of CEO Ashley McEvoy's first changes since she was hired in April. The appointments come after McEvoy outlined four priorities for Insulet on an August earnings call:   enhancing the company's commercial capabilities, building Insulet's brand and direct-to-consumer capabilities, driving growth outside of the U.S. and accelerating the pace of innovation. https://www.medtechdive.com/news/insulet-eric-benjamin-manoj-raghunandanan-appointments/758668/ XX   XX Want to highlight The Children's Diabetes Foundation in Colorado – they held a medal ceremony for patients of the Barbara Davis Center who've lived with Type 1 diabetes for 50 years or more. There were 87 medal recipients in the ceremony including Dana Davis, Executive Director of the Children's Diabetes Foundation and the daughter of the founders of the Barbara Davis Center. Davis shared: "When you got Type1 diabetes in the 70s, they thought you shouldn't have children. They thought you weren't going to live past 30 or 40. It was definitely very different," Davis said.   https://www.cbsnews.com/colorado/news/barbara-davis-center-celebrates-colorado-type-1-diabetes-patients-milestone/

In this episode, Journal of Prosthetics and Orthotics editor-in-chief Dr. Steve Gard speaks with Jeremy Sherman, MS, CPO, LPO, associate program director and assistant professor in the Orthotics and Prosthetics program at Baylor College of Medicine. They discuss Sherman's study on developing a hand skills testing methodology for O&P, highlighting the challenges and importance of objectively evaluating student proficiency. The conversation explores the creation and refinement of rubrics, the testing methods used at Baylor, and key findings that showed skill improvement through practice and repetition. Sherman also reflects on the broader implications for O&P educators and how similar methodologies could be adopted by other programs. Show notes JPO article: Development of Hand Skills Testing Methodology for O&P Curriculum   O&P Research Insights is produced by Association Briefings.

In this episode of the SRNA "Ask the Expert" podcast moderated by Dr. GG deFiebre, Dr. Kyle Blackburn and Dr. Benjamin Greenberg discussed the need for updated diagnostic criteria for myelitis. Dr. Blackburn explained the term myelitis and the importance of precise terminologies for accurate diagnoses and research [00:05:10]. Dr. Greenberg elaborated on the advancements in testing and understanding of associated disorders like NMOSD and MOGAD since 2002 [00:11:10]. Both experts stated that the shift from "transverse myelitis" to "myelitis" will aid future research, treatments, and patient care [00:17:27]. They reassured patients that these changes would essentially refine their care but not alter it dramatically [00:23:40]. They encouraged patients to stay informed and communicate with their healthcare providers about these updates [00:28:58].Kyle Blackburn, MD is an Assistant Professor in the Department of Neurology at UT Southwestern Medical Center in Dallas, Texas. He specializes in neuroimmunology and has clinical interests in antibody-mediated neurologic disorders, including autoimmune encephalitis, epilepsy, and ataxias; neurologic complications of cancers, including paraneoplastic disorders and checkpoint inhibitor/CAR T-cell toxicity; and demyelinating disorders, including sarcoidosis, neuromyelitis optica, myelin oligodendrocyte glycoprotein (MOG)-associated disease, and multiple sclerosis. Dr. Blackburn earned his medical degree at the University of Kentucky College of Medicine. He performed his residency in adult neurology at UT Southwestern, serving his final year as Chief Resident, and stayed to complete a fellowship in neuroimmunology, during which he earned the James T. Lubin Clinician Scientist Award from the Siegel Rare Neuroimmune Association (SRNA). He joined the UT Southwestern faculty in 2020.Benjamin M. Greenberg, M.D., M.H.S. is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center.Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients. 00:00 Introduction00:58 Overview of Myelitis and Diagnostic Criteria02:57 Historical Context and Importance of Updated Criteria05:10 Challenges with Current Terminology11:10 Changes in Understanding and Diagnostic Approaches17:27 Implications for Patients and Clinical Practice23:40 Impact on Research and Future Directions28:58 Patient Advocacy31:17 Conclusion

We love to hear from our listeners. Send us a message.This is Episode 3 of "FDA Fridays," a 4-week special series from Cell & Gene: The Podcast. Host Erin Harris talks to Bambi Grilley, Ph.D., Professor of Pediatrics and the Director of Clinical Research and Early Product Development for the Center of Cell and Gene Therapy (CAGT) at Baylor College of Medicine and Chief Regulatory Officer for ISCT, a leading expert at the forefront of pediatric cell and gene therapy. Dr. Grilley shares her wealth of experience and unique perspective on the most pressing barriers to accessing transformative treatments for children, from logistical and financial challenges faced by families, to systemic and regulatory hurdles in getting therapies from the lab to the clinic.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn

Are typical mouthwash products effective and are they worth recommending to our patients? Are there any products out there that can actually make a significant difference in our fight against perio disease? Our guest, Dr. Steven Milman, will address these questions and more. Dr. Milman received his dental degree from Baylor College of Dentistry in Dallas, Texas. He completed his Periodontal residency at the University of Texas Health Science Center in San Antonio. He was a researcher in periodontal microbiology and was a full time periodontist in his private practice in Round Rock and Austin, Texas for 36 years. Thanks to our episode sponsors: BISCO - https://www.bisco.com/ Solventum - https://www.solventum.com/en-us/home/oral-care/

#ThisMorning #Wellness | #Liver #Cancer Cases are Expected to #Double by 2050 | Hashem El-Serag, Baylor College of Medicine | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #wellness

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Kenneth Liao, professor of surgery and chief of the Division of Cardiothoracic Transplantation and Circulatory Support at Baylor College of Medicine, about performing the world's first adult robotic heart surgery in the United States using a subxiphoid approach. Chapters 00:00 Intro 02:31 JANS 1, Endocarditis Guidelines 13:02 JANS 2, Hybrid vs Catheter 16:16 JANS 3, Full Sternotomy Trial 18:07 JANS 4, Buttressing the BA 19:05 JANS 5, Intraspinal Vasc Perf 20:15 Career Center 20:37 Video 1, Root Replace & Ann Reconstr 21:56 Video 2, Bi-Atrial Cann for BVAD 24:17 Video 3, Pediatric Device Implant 26:23 Dr. Liao Interview 49:07 Upcoming Events 49:39 Closing They discuss the details of the procedure, including its background, ischemic time, technique, and postoperative outcomes. Additionally, they explore the application of the subxiphoid approach for robotic heart transplants and robotic mitral valve repair vs traditional open-chest (sternotomy) repair. Dr. Liao shares insights into the training and practice required for this operation and discusses the advantages of using robotics in heart transplants. He also reflects on what he would do differently in future procedures.   Joel also highlights recent JANS articles on the surgical implications of the 2023 ESC endocarditis guidelines endorsed by EACTS, the two-year results from the randomized CEASE-AF trial on the durable effectiveness and safety of hybrid ablation vs catheter ablation, a randomized trial on superficial parasternal intercostal plane block and full sternotomy, a comparison of the short- and long-term outcomes in patients undergoing sleeve lobectomy with or without buttressing the bronchial anastomosis, and intraspinal vascular perfusion territories of the descending thoracic aorta.  In addition, Joel explores free-style root replacement and annular reconstruction for destructive aortic root endocarditis, bi-atrial cannulation for biventricular assist device in children, and a device implantation in a 26 kg child. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) Surgical Implications of the 2023 ESC Endocarditis Guidelines Endorsed by EACTS: Bridging Guidelines and Practice   2.) Durable Effectiveness and Safety of Hybrid Ablation Versus Catheter Ablation: 2-year Results From the Randomized CEASE-AF Trial  3.) Superficial Parasternal Intercostal Plane Block and Full Sternotomy; A Randomized Trial  4.) Comparison of Short- and Long-Term Outcomes in Patients Undergoing Sleeve Lobectomy With or Without Buttressing the Bronchial Anastomosis  5.) Intraspinal Vascular Perfusion Territories of the Descending Thoracic Aorta  CTSNET Content Mentioned  1.) Free-Style Root Replacement and Annular Reconstruction for Destructive Aortic Root Endocarditis  2.) Bi-Atrial Cannulation for Biventricular Assist Device in Children  3.) Device Implantation in a 26 kg Child  Other Items Mentioned  1.) Guest Editor Series Webinar: Insights Into Pediatric Mechanical Circulatory Support  2.) Cardiac Surgical Arrest—An International Conversation Series    3.) Career Center   4.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

PURCHASE THIS PODCOURSE! If you are a therapist or counselor looking for continuing education, check out my NBCC Approved $5 Podcourses and other continuing education offerings.Plus, get your first Podcourse half off. Since 2009, rates of anxiety, depression, and suicidality among young people have risen sharply, and research points to smartphones and social media as major contributors. In this episode, I talk with Dr. Johann D'Souza, a clinical psychologist specializing in OCD and anxiety, about what is driving this crisis and how we can respond. We unpack the four harmful effects of excessive screen time: sleep deprivation, addiction, social isolation, and distraction. We also explore evidence-based solutions that work. From creating phone-free schools to encouraging unstructured play and family screen detoxes, you will hear practical steps parents, therapists, and communities can take to protect youth well-being.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Todd Rosengart, professor and chair of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, about his team performing the world's first adult robotic heart surgery in the United States. Chapters 00:00 Intro 02:27 JANS 1, On-Table Extubation 14:13 JANS 2, Intraop Broncho Biopsies 18:26 JANS 3, Stroke After Transplant 20:51 JANS 4, Pulm Carcinoid Tumors 22:56 Career Center 24:05 Video 1, Robotic LAAO 25:36 Video 2, Bedside VV ECMO 26:44 Video 3, Inverted Y AE 28:01 Dr. Rosengart Interview, Novel Approaches 40:57 Upcoming Events 42:58 Closing They discuss postoperative outcomes and the 100-day follow-up appointment, the benefits of the robotic technique in transplants, and the surgeons who participated in this procedure. Additionally, Dr. Rosengart shares advice for individuals performing robotic transplants, his experience leading this unit, and its notable accomplishments, including other world-first procedures.   Joel also highlights recent JANS articles on the 10 best practices of on-table extubation after cardiac surgery, if we can rely on intraoperative bronchoscopic biopsies for surgical decision making, increased prevalence of stroke after heart transplant in the new allocation system era, and the surgical management of both stage III and stage IV pulmonary carcinoid tumors confers survival benefit.  In addition, Joel explores robotic left atrial appendage occlusion, bedside veno-venous extracorporeal membrane oxygenation cannulation technique in an awake patient, and a stepwise surgical approach for inverted Y annular enlargement in the bicuspid aortic valve. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) The 10 Commandments of On-Table Extubation After Cardiac Surgery: Why and How to Increase Adoption  2.) Can We Rely on Intraoperative Bronchoscopic Biopsies for Surgical Decision Making? 78 Single Anesthetic Robotic Bronchoscopy to Anatomic Resections  3.) Increased Prevalence of Stroke After Heart Transplant in the New Allocation System Era  4.) Surgical Management of Both Stage III and Stage IV Pulmonary Carcinoid Tumors Confers Survival Benefit  CTSNET Content Mentioned  1.) Robotic Left Atrial Appendage Occlusion   2.) Bedside Veno-Venous Extracorporeal Membrane Oxygenation Cannulation Technique in an Awake Patient  3.) Inverted Y Annular Enlargement in Bicuspid Aortic Valve: A Stepwise Surgical Approach  Other Items Mentioned  1.) Guest Editor Series: Insights Into Pediatric Mechanical Circulatory Support  2.) Cardiac Surgical Arrest—An International Conversation Series    3.) Career Center   4.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Estás escuchando #JUNTOSRadio: ¿Qué es el lupus?, ¿cómo puedo identificar los síntomas?, ¿esta enfermedad afecta a la comunidad latina? El Doctor Brad Nelson nos responde a estas y otras preguntas. Sobre nuestro invitado: El Dr. M. Brad Nelson es Profesor Clínico Adjunto de Pediatría con un nombramiento conjunto en la División de Alergia, Inmunología Clínica y Reumatología de la Facultad de Medicina de la Universidad de Kansas / Sistema de Salud de la Universidad de Kansas. Después de completar su Maestría en Salud Pública y Doctorado en Medicina en la Facultad de Medicina de la Universidad de Kansas, el Dr. Nelson completó su pasantía y residencia en Pediatría en la Facultad de Medicina de la Universidad de Utah / Hospital Pediátrico Primario en Salt Lake City, UT. Durante su residencia, también completó un programa de certificado en Bioética Pediátrica a través de la Facultad de Medicina de la Universidad de Missouri-Kansas City / Hospital Pediátrico Mercy en Kansas City, MO. Posteriormente, el Dr. Nelson realizó una beca en Reumatología Pediátrica en el Baylor College of Medicine / Hospital Pediátrico de Texas en Houston, TX. Además de brindar atención clínica, el Dr. Nelson tiene intereses en la educación de estudiantes de medicina, residentes y becarios, la investigación en las áreas de determinantes sociales y resultados en enfermedades crónicas pediátricas y la integración de la atención de salud mental en la atención de niños con enfermedades crónicas. Recursos en español Lupus en la comunidad latina: https://www.gladel.org/gladelspa/acer... Facebook: @juntosKS Instagram: juntos_ks YouTube: Juntos KS Twitter: @juntosKS Página web: http://juntosks.org Suscríbete en cualquiera de nuestras plataformas de Podcast: Podbean, Spotify, Amazon Music y Apple Podcast - Juntos Radio Centro JUNTOS Para Mejorar La Salud Latina 4125 Rainbow Blvd. M.S. 1076, Kansas City, KS 66160 No tenemos los derechos de autor de la música que aparece en este video. Todos los derechos de la música pertenecen a sus respectivos creadores.

Bienvenidos a la quinta temporada de Pediatras en Línea, un podcast creado para conectar a profesionales de la salud con experiencias, herramientas y modelos innovadores que están transformando el cuidado pediátrico en nuestras comunidades. Hoy tenemos un episodio dirigido a ustedes: pediatras, médicos de atención primaria, residentes y profesionales que trabajan con pacientes pediátricos hispanohablantes.  Nos acompañan dos cirujanos pediatras de Children's Hospital Colorado que lideran una iniciativa única en su tipo: una clínica de cirugía pediátrica completamente en español. Conoceremos cómo funciona este modelo, su impacto en la atención, y cómo puede servir como inspiración para replicarlo en otros sistemas de salud. El Dr. José Luis Díaz-Mirón es originario de Nuevo Laredo, Tamaulipas, México. Estudió medicina en Baylor College of Medicine, en Houston, Texas y completó su residencia en cirugía general en Washington University School of Medicine, en San Luis, Missouri. La especialidad en cirugía pediátrica la realizó en la Universidad de Michigan, Ann Arbor. El Dr. Jonathan Hills-Dunlap estudió en la escuela de medicina de la Universidad de Stanford. Cuenta con una maestría en salud pública de la Escuela de Salud Pública de Harvard. Su residencia la cursó en Brigham and Women's Hospital y en la Escuela de Medicina de Harvard. Realizó un fellowship de Investigación en Servicios de Salud Pediátrica de Harvard en el Boston Children's Hospital y la subespecialidad de Cirugía Pediátrica en el Children's Hospital Colorado en la Universidad de Colorado. Actualmente ambos trabajan en Children's Hospital Colorado donde han desarrollado la primera clínica en el estado de Colorado para pacientes de habla hispana. Clínica de cirugía pediátrica de habla hispana . Click or tap if you trust this link." id="OWA0ed31062-1cc1-9dc2-f276-b96e9f292da1" href="Clínica de cirugía pediátrica de habla hispana ">Clínica de Cirugía Pediátrica | Children's Hospital Colorado (Children's Hospital Colorado ) ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast?  Escríbenos a pediatrasenlinea@childrenscolorado.org.

CardioNerds (Dr. Rick Ferraro and Dr. Dan Ambinder) join Dr. Sahar Samimi and Dr. Lorraine Mascarenhas from Baylor College of Medicine, Houston, Texas, at the Houston Rodeo for some tasty Texas BBQ and a tour of the lively rodeo grounds to discuss an interesting case full of clinical pearls involving a patient with nonbacterial thrombotic endocarditis (NBTE). Expert commentary is provided by Dr. Basant Arya. Episode audio was edited by CardioNerds Intern Dr. Bhavya Shah. (Photo by Xu Jianmei/Xinhua via Getty Images)Xinhua News Agency via Getty Images We discuss a case of a 38-year-old woman with advanced endometrial cancer who presents with acute abdominal pain, found to have splenic and renal infarcts, severe aortic regurgitation, and persistently negative blood cultures, ultimately diagnosed with nonbacterial thrombotic endocarditis (NBTE). We review the definition and pathophysiology of NBTE in the context of malignancy and hypercoagulability, discuss initial evaluation and echocardiographic findings, and highlight important management considerations. Emphasis is placed on the complexities of anticoagulation choice, the role of valvular surveillance, and the need for coordinated, multidisciplinary care.   US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls- Nonbacterial Thrombotic Endocarditis Eliminate the Usual Suspects. NBTE is a diagnosis of exclusion! Always rule out infective endocarditis (IE) first with serial blood cultures and serologic tests.  More than Meets the Echo. Distinguishing NBTE from culture-negative endocarditis can be tricky. Look beyond the echo—focus on clinical context (underlying malignancy, autoimmune issues) and lab findings to clinch the diagnosis.  TEE for the Win... Mostly. While TEE is more sensitive than TTE, NBTE vegetations can be sneaky and may embolize quickly. Don't hesitate to use advanced imaging (i.e., cardiac MRI, CTA) or repeat imaging if you still suspect NBTE.  Choose your champion. In cancer-associated NBTE, guideline recommendations for anticoagulation choice are lacking. Consider DOACs and LMWH as agents of choice, but ultimately use shared decision-making to guide management.  No obvious trigger? Go hunting for hidden malignancies or autoimmune disorders. A thorough workup is essential to uncover the driving force behind NBTE.  Check out this state-of-the-art review for a comprehensive, one-stop summary of NBTE: European Heart Journal, 46(3), 236–245. Please note that the figures and tables referenced in the following notes are adapted from this review.  notes- Nonbacterial Thrombotic Endocarditis Notes were drafted by Dr. Sahar Samimi.  What is nonbacterial thrombotic endocarditis (NBTE)?   NBTE, previously known as marantic endocarditis, is a rare condition in which sterile vegetations form on heart valves.1  It occurs most commonly in association with malignancies and autoimmune conditions (i.e, antiphospholipid antibody syndrome or systemic lupus erythematosus).1 In addition, NBTE has been reported in association with COVID-19 infection, burns, sepsis, and indwelling catheters.2  Precise mechanisms remain unclear, but an interplay of endothelial injury, hypercoagulability, hypoxia, and immune complex deposition contributes to the formation of these sterile vegetations. 1  How do we diagnose NBTE?  Physicians should have a high level of suspicion for NBTE in at-risk patients (e.g., with active malignancy) who present with recent or recurrent embolic events (i.e., stroke, splenic, renal, or mesenteric infarct, and acute coronary syndrome).1 

Dr. Paul Ling is a professor in the Department of Microbiology and Virology at Baylor College of Medicine. He also serves as an advisor to Colossal Biosciences. Following the death in 2010 of a 2-year-old elephant at the Houston zoo due to elephant endotheliotropic herpes virus (EEHV), Dr. Ling formed a cooperative effort with the zoo and others within the community to address this highly lethal disease. Thanks to this partnership and significant funding from the Houston zoo, a mRNA vaccine was successfully introduced last year to a few vulnerable individuals at the Cincinnati zoo.  Other key partners in the development of diagnostics, therapeutics and ultimately, the vaccine include: Dr. Jeroen Pollet of the National School for Tropical Medicine, the International Elephant Foundation (IEF), Colossal Biosciences, and the Houston Methodist Center for RNA Therapeutics. https://www.houstonzoo.org/houston-zoo-leads-the-way-in-eehv-research/ Animal Care Software

Matthew Halpert, PhD—immunologist and CEO of Immunocine—joins The Moss Report to discuss an important discovery: a new way to fully activate dendritic cells, the “coaches” of the immune system. When these cells switch on, they can recognize and attack cancer. We talk about what this could mean for the future of immunotherapy: approaches that are more targeted, potentially less toxic, and designed to help the body find what it has been missing. Dr. Halpert explains the insight behind the method, how it differs from current treatments, what early experience looks like, and the key questions that still need testing. If you follow immunotherapy—or are weighing options—this conversation captures a major step forward in understanding how the immune system can be guided to fight cancer. Full article on The Moss Report with transcript: https://www.themossreport.com/immunocine-cancer-center/ Glossary of Terms  https://docs.google.com/document/d/140Gt8VNgexyu-2vjfOgTdPdOqlaFAsvLTOVWLyGwGgE/edit?usp=sharing Cited Paper: MHC class I and II peptide homology regulates the cellular immune response - https://pubmed.ncbi.nlm.nih.gov/32298026/ PubMed - Original Article in FASEB  https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.201903002R Immunocine Cancer Center - https://immunocine.com/meet-the-immunocine-team/ Baylor College of Medicine - https://www.bcm.edu/ Resources:

In this episode of the Big T Trauma Series, Dr. Patrick Georgoff (@georgoff) and Dr. Jason Brill dive into the evolving world of Trauma Video Review (TVR) with special guests Dr. Michael Vella and Dr. Ryan Dumas. Together, they explore how TVR is transforming trauma care by offering unprecedented insight into both technical and non-technical performance in the trauma bay. The conversation covers everything from implementation logistics and HIPAA concerns to cultural shifts and emerging AI applications. Whether you're curious about getting started or wondering if TVR should be part of trauma verification, this episode delivers essential insights from two national leaders in the space. Don't miss it! Dr. Ryan Dumas is an associate professor of surgery at Baylor College of Medicine in Houston Texas where he serves as the Section Chief of Acute Care Surgery.  Dr. Dumas conducts and publishes research in trauma surgery and artificial intelligence, with a specific emphasis on video technology to capture and review trauma resuscitations. He has helped develop and run several Trauma Video Review programs across the country and utilizes video review as a tool for quality improvement, education, and research. Dr. Dumas is a consultant for Teleflex and Surgical Safety Technologies. Dr. Michael Vella is an associate professor of surgery, division of acute care surgery and trauma, at the university of Rochester medical center in Rochester, NY and the trauma medical director of the Kessler Level I trauma center.  He currently serves as chair of the New York State Committee on Trauma.  He has a clinical and research interest in trauma video review, particularly as it relates to trauma team dynamics and initial resuscitation.  Dr. Dumas is a consultant for Teleflex. This episode of Big T Trauma was sponsored by Teleflex, a global provider of medical devices. Learn more at teleflex.com and at the Teleflex Trauma and Emergency Medicine LinkedIn page. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode, Journal of Prosthetics and Orthotics editor-in-chief Dr. Steve Gard sits down with Jeremy Sherman, MS, CPO, LPO, the associate program director for the orthotics and prosthetics program, and an assistant professor in the School of Health Professions at Baylor College of Medicine. Together, they explore Sherman's research on ergonomic challenges, overuse injuries, and the widespread prevalence of pain among O&P professionals across the U.S. Drawing from his background in mechanical engineering and patient-centered care, Sherman shares what led him to investigate the physical toll of clinical work. The conversation highlights key findings, including the disproportionate impact on early-career practitioners and the critical need for more adaptable, ergonomic clinical environments to ensure career longevity and provider well-being. Show notes JPO article: Insights into Overuse: Ergonomic Trends and Pain Prevalence Among Orthotics and Prosthetics Practitioners in the United States   O&P Research Insights is produced by Association Briefings.

In this episode of the Dr. Geo Prostate Podcast, Dr. Geo welcomes Dr. Mohit Khera, a globally recognized leader in men's health, Professor of Urology and Director of the Executive Health Program at Baylor College of Medicine. With over 160 peer-reviewed publications and decades of clinical experience in testosterone therapy, male infertility, and prostate health, Dr. Khera shares cutting-edge insights on testosterone replacement therapy (TRT), including the rise of oral testosterone like Kyzatrex, and the evolving understanding of testosterone's relationship to prostate cancer.Whether you're considering TRT, recovering from prostate cancer, or supporting a loved one's health journey, this conversation brings clarity to one of men's most pressing health topics.What You'll Learn:The 4 C's framework to determine the best TRT option:Cost, Compliance, Convenience, ConcentrationWhy oral testosterone (Kyzatrex, Tlando, Jatenzo) is gaining traction—and what makes them differentHow Kyzatrex may help preserve fertility by reducing gonadotropin suppressionWhat the TRAVERSE trial revealed about TRT and cardiovascular safetyWhy low testosterone may be linked to more aggressive prostate cancerWhat the latest science says about BAT (Bipolar Androgen Therapy) for advanced prostate cancerThe truth about testosterone's impact on BPH and urinary symptomsWhy total testosterone isn't enough—labs like SHBG, DHT, estradiol, and free testosterone matterKey Insights:TRT doesn't cause prostate cancer — and may even have protective effects in some men.Testosterone is the best barometer of male health—predicting cardiovascular risk, mood, bone density, and more.BAT (Bipolar Androgen Therapy) is showing promise in treating advanced prostate cancer in specific scenarios.Avoid unnecessary aromatase inhibitors and DHT blockers unless clinically indicated.

Remembering why you first entered the wonderful and challenging world of academic medicine might be just the boost of joy you need to uncover to stave off burnout. Our guest this week on the Faculty Factory Podcast is Geeta Singhal, MD, MEd, FAAP, whom we warmly welcome for her first-ever (and very memorable) appearance on our program. She does a brilliant job painting a picture for us of ways to uncover joy amidst the challenges of patient care, teaching, research, and many other rich, rewarding, and difficult tasks of the academic medicine journey. Dr. Singhal currently serves as Executive Vice Chair of the Department of Pediatrics, Professor of Pediatrics, Director of Academics in the Division of Pediatric Hospital Medicine, Attending Physician, and Co-Director of Pediatric Hospital Medicine at Baylor College of Medicine (BCM). She is also a Faculty Leadership Development Program Partner at BCM and a Professionalism Partner at Texas Children's Hospital.  Learn more: http://facultyfactory.org/Geeta-Singhal 

Want to elevate your infection prevention career? Dive into this inspiring episode with Gail Fraine and Dr. Mayar Al Mohajer as they explore the value, purpose, and impact of the Advanced Leadership Certification in Infection Prevention (AL-CIP). Learn how this credential empowers professionals to lead change, drive outcomes, and shape healthcare policy. Get tips for submission success and hear firsthand experiences from these certified leaders! Hosted by: Kelly Holmes, MS, CIC, FAPIC and Lerenza L. Howard, MHA, CIC, LSSGB About our Guests: Gail Fraine, CIC, LTC-CIP, AL-CIP Gail Fraine is the System Director of Infection Prevention at Ascension Saint Thomas in Nashville, TN, with over 30 years of experience reducing healthcare-associated infections through evidence-based practices and high-reliability principles. A long-standing APIC member, she has held national leadership roles including Board Director and Annual Conference Chair. Gail currently serves as President-Elect of the Certification Board of Infection Control and Epidemiology (CBIC) and contributed to developing both the long-term care and Advanced Leadership certifications. She holds nursing degrees from Arkansas State, Belmont, and Vanderbilt, and is certified in CIC, LTC-CIP, and AL-CIP. Mayar Al Mohajer, FIDSA, FSHEA, FAPIC, FACHE, AL-CIP Dr. Al Mohajer serves as Professor of Medicine in the Section of Infectious Diseases at Baylor College of Medicine in Houston, Texas, where he also directs the Infection Prevention, Antimicrobial Stewardship, Quality Improvement, and Leadership Track. He is the Chief of the Infectious Disease Section at Baylor St. Luke's Medical Center and the Medical Director of Infection Prevention, Occupational Health, Diagnostic Stewardship, and Antibiotic Stewardship for CommonSpirit Health's South Region and Baylor St. Luke's Medical Center. In addition to his clinical and academic roles, Dr. Al Mohajer sits on the CBIC Board and co-chairs the National Infection Prevention Council for CommonSpirit Health. He holds multiple fellowships and certifications recognizing his expertise and leadership, including FIDSA, FSHEA, FAPIC, FACHE, and AL-CIP.

Dr. Madhuri Vasudevan is a board-certified endocrinologist and faculty member at Baylor College of Medicine, known for her integrative approach to healing that unites science, nutrition, and holistic wellness. Through her work--especially with veterans at the VA--she empowers patients to thrive by harnessing their body’s natural ability to heal, using both medical therapies and lifestyle-based […]

In episode 51 of Going anti-Viral, Dr Peter Hotez joins host Dr Michael Saag to provide an update on the measles outbreak in the US and discuss the role that anti-science plays in threatening public health. Dr Hotez is a Professor of Pediatrics and Molecular Virology and Microbiology at Baylor College of Medicine. He is the author of more than 700 scientific papers and four books and is an ardent vaccine advocate and “science explainer” who combats anti-science and antisemitism in America, and globally. Dr Hotez and Dr Saag provide an overview of the current measles outbreak in the United States and the high rate of transmission. They discuss efforts to increase rates of vaccination, especially in a climate of misinformation about the safety and efficacy of the measles vaccine. Dr Saag and Dr Hotez discuss the origins of misinformation during the COVID-19 pandemic, including a discussion of the incentives of health and wellness influencers to spread false information. They also discuss how best to distribute accurate health information about vaccines on social media. They conclude by reviewing the successful history of childhood vaccination programs and the risk of future pandemics in a climate of disinformation about vaccination. 0:00 – Introduction1:56 – Measles and risk of transmission 6:24 – Efforts to increase rates of vaccination and discussion of anti-vaccine sentiment  10:40 – Growth of anti-vaccine sentiment during COVID-19 and health and wellness influencers distributing false health information 17:46 – How to best to distribute accurate health information on social media 22:35 – Conflict of interest among anti-vaccine influencers 27:47 – The success of childhood vaccination and the risk of future pandemics given vaccine disinformation __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

En este episodio de Más Que Raras, tenemos el privilegio de conversar con el Dr. Carlos Bacino, un referente internacional en genética molecular y humana. Con una sólida formación académica y décadas de experiencia, el Dr. Bacino ha dedicado su carrera al diagnóstico y tratamiento de enfermedades genéticas raras. Actualmente dirige la Clínica del Síndrome de Angelman y el laboratorio de citogenética en Baylor Genetics, desde donde lidera esfuerzos pioneros en investigación clínica y atención personalizada. En esta entrevista, nos habla de los avances científicos en su campo, su compromiso con las familias afectadas y la importancia de construir puentes entre la ciencia y la comunidad. Una conversación profunda y esperanzadora que no se pueden perder.   Más información:  El proyecto Texome: https://www.texome.org/ Centro de Enfermedades No Diagnosticadas en Baylor College of Medicine: https://www.bcm.edu/research/research-centers/undiagnosed-diseases-center   Fundación para la terapéutica del síndrome de Angelman (FAST LATAM) https://cureangelman.lat/   En Catalyst Pharmaceuticals, una empresa biofarmacéutica comprometida a mejorar las vidas de los pacientes con enfermedades poco frecuentes, entendemos los desafíos únicos de afecciones como la Distrofia Muscular de Duchenne y el Síndrome Miasténico de Lambert-Eaton (LEMS). Guiados por nuestro compromiso profundo hacia el cuidado del paciente, priorizamos la accesibilidad, al brindar un paquete integral de servicios de apoyo diseñados para acceso ininterrumpido y asistencia continua. Reconocemos que cada proceso es personal y puede ser difícil. Por eso es que nos dedicamos a brindar mucho más que tratamiento: estamos a su lado para apoyarlo a cada paso del camino.  Para obtener más información, visite catalystpharma.com  Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook BloodStream on Twitter    

In this episode, Dr. Alexis Wood, a leading researcher at Baylor College of Medicine, joins me to unpack insights into childhood nutrition, genetics, and cognitive health. Dr. Wood's work bridges genetics, dietary practices, and brain development, highlighting how early-life nutrition can shape lifelong outcomes. We explore cutting-edge research, practical strategies for parents, and the surprising factors influencing children's cognitive and metabolic health.We cover:Why childhood nutrition and genetics have been historically overlooked—and what it means for your family.ADHD and diet: Separating fact from fiction.Debunking popular diet myths: What the research actually says about red meat and processed foods.Cognitive self-regulation: The hidden link between diet, obesity, and ADHD. Precision nutrition & metabolomics: The future is more than one-size-fits-all advice.Whether you're a parent, educator, or health professional, this conversation offers guidance on navigating the complex relationship between nutrition, genetics, and childhood development.Who is Dr. Alexis Wood?Dr. Alexis Wood, Ph.D., F.A.H.A., is an Associate Professor of Pediatrics–Nutrition at Baylor College of Medicine's USDA/ARS Children's Nutrition Research Center. Her research integrates genetics, child development, and nutrition, focusing on how genetic factors influence responses to diet and behavior.This episode is brought to you by: PaleoValley - Get 15% off at https://paleovalley.com/drlyonARMRA – Use code DRLYON to get 15% off your first order at https://tryarmra.com/DRLYONOur Place - Use code DRLYON for 10% off sitewide – https://fromourplace.com/DRLYON Timeline - Get 20% off your order of Mitopure - https://timeline.com/LYONFind Dr. Alexis Wood at: Linked In - https://www.linkedin.com/in/lekkiwood/Baylor College of Medicine - https://www.bcm.edu/people-search/alexis-wood-33281USDA/ARS Children's Nutrition Research Center - https://www.bcm.edu/research/research-centers/usda-ars-childrens-nutrition-research-centerAlexis Wood Lab - https://www.bcm.edu/research/faculty-labs/alexis-lekki-wood-labFind Me At: Instagram:@drgabriellelyon TikTok: @drgabriellelyonFacebook: facebook.com/doctorgabriellelyonYouTube: youtube.com/@DrGabrielleLyonX (Twitter): x.com/drgabriellelyonApply to become a patient –

I'm joined today by two special guests to discuss an unusual and ethically complex type of organ donation – imminent death donation, or IDD. As you'll hear Thao Galvan explain in the episode, organ donation currently has three standard types: living donation, donation after brain death (a type of deceased donation in which the patient is declared brain dead, and thus legally dead), and donation after circulatory death, or DCD. In DCD, a patient who is not brain dead is removed from life support, but the heart keeps beating. If it takes the patient more than roughly 90 minutes to die, the organs may not be usable. IDD, or imminent death donation, attempts to prevent that, by retrieving non-vital organs (usually a kidney) for donation prior to the removal of life support. Thao Galvan is a transplant surgeon and professor of surgery at Baylor College of Medicine. Kathy Osterrieder is a retired financial analyst, who came to this issue after attempting, unsuccessfully, to donate the organs of her late husband, Robert Osterrieder, after making the difficult decision to remove him from life support. It is another first for the Taboo Trades podcast – the first time in over five years of recording that I've been unable to hold back the tears, as Kathy talks about what the experience was like for her family. LinksHost: Kimberly D. Krawiec, Charles O. Gregory Professor of Law, University of VirginiaGuests: Nhu Thao Nguyen Galvan, M.D., M.P.H., FACS, Associate Professor of Surgery, Baylor College of MedicineKathleen Osterrieder, Donor Family Member in Spirit, Retired Financial AnalystReading: The Difficult Ethics of Organ Donations From Living Donors, Wall St. J. (2016)Let's change the rules for organ donations — and save lives, Wash. Post (2019)OPTN, Ethical considerations of imminent death donation white paper (2016)Survey of public attitudes towards imminent death donation in the United States, Am. J. Transplant. (2020)

What if instead of treating illness we also confronted the reasons Americans get sick in the first place? That's the origin of this podcast and also the 4 billion dollar question Dr. Bechara Choucair is tackling at Kaiser Permanente. Bechara, who is KP's Chief Community Health Officer, joins Claudia to talk about the organization's focus on climate change and health, workforce pipelines and addressing broader social needs.We discuss:The surprising fact that two-thirds of KP's members (who are mostly covered by employer insurance) have at least one unmet social needThe common sense moves the Common Health Coalition is taking to build bridges between healthcare and public healthWhat KP is doing to tackle a big problem limiting the mental health workforce: only 57% of masters trained therapist get licensedWhat it took for KP to achieve carbon neutralityBechara reminds us that bridge-building is a crucial part of this community health work:“We need more and more bridges between public health and healthcare... [They have] operated as two separate disciplines operating in their own silos... [When] there is a public health emergency we build more bridges, we strengthen those bridges that already exist. And then when that public health emergency subsides, we all retreat into our own disciplines and we continue that siloed journey.”Relevant LinksRead about the NAM initiative on climate change and healthExplore why the US needs more community health workers from this articleLearn more about the Common Health CoalitionDive into details on KP's sustainability journeyAbout Our GuestDr. Bechara Choucair, MD, is executive vice president and chief community health officer for Kaiser Foundation Health Plan, Inc. and Hospitals — known as Kaiser Permanente, one of America's leading integrated health care providers and not-for-profit health plans. Dr. Choucair oversees the organization's national community health efforts and philanthropic giving activities aimed at improving the health of its 12.2 million members and the 68 million people within the communities it serves.Previously, Dr. Choucair served as senior vice president, Safety Net and Community Health, at Trinity Health, and was the commissioner of the Chicago Department of Public Health.Dr. Choucair, a family physician by training, completed his Family Practice Residency at Baylor College of Medicine in Houston, Texas. He holds an MD from the American University of Beirut and a master's degree in health care management from the University of Texas at Dallas.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter

Intern year: where the learning curve is steep and you're not sure if the patient is crashing or you are. In this episode of Behind the Knife, our surgical education fellows reflect on what they wish they had known before Day 1—and all the humbling, hilarious, and genuinely formative moments along the way. From getting lost wheeling a critical patient through the hospital, to triple-scrubbing just to be acknowledged, to accidentally spraying TPA into your own eye (yes, really)—this episode is a candid conversation about the highs, lows, and everything in between. Whether you're gearing up to start your intern year or reflecting on how far you've come, this is the episode we all needed. Hosts:  Elizabeth Maginot, MD – General Surgery Resident, University of Nebraska Medical Center  @e_magination95 Nina Clark, MD – General Surgery Resident, University of Washington @clarkninam Ayman Ali, MD – General Surgery Resident, Duke University Michelle LaBella, MD – General Surgery Resident, University of North Carolina Emma Burke, MD – General Surgery Resident, Baylor College of Medicine @emmaburke017 Learning Objectives: Identify common misconceptions about intern year—and how to manage expectations Understand how to approach early mistakes with humility and resilience Recognize the importance of teamwork and asking for help Reflect on what makes a strong, dependable intern References BTK Intern Survival Guide: https://app.behindtheknife.org/podcast-series/medical-student-and-intern-survival-guide Institutional pharmacists (seriously, call them—they're the unsung heroes) Check out our Medical Student and Intern Survival Guide HERE: https://app.behindtheknife.org/podcast-series/medical-student-and-intern-survival-guide

Can we do more than prescribe pills to address men's sexual health complaints? In this episode of the BackTable Urology Podcast, men's health expert Dr. Mohit Khera from Baylor College of Medicine joins guest host Dr. Amy Pearlman for a deep dive into testosterone management and the full spectrum of erectile dysfunction therapies. --- SYNPOSIS The conversation covers daily tadalafil use, lifestyle optimization, and the nuanced role of off-label medications. Dr. Khera also highlights emerging technologies like the Tech Ring and radiofrequency treatments, alongside practical insights into semen analysis and hormonal health markers. Throughout, he emphasizes a holistic, patient-centered approach to sexual health—blending medical therapy with meaningful lifestyle change. This is a must-listen for general urologists, men's health specialists, and trainees looking to expand their toolkit in this evolving field. --- TIMESTAMPS 00:00 - Introduction02:13 - Erectile Dysfunction and Testosterone08:05 - Young Men's Health and Early Detection10:20 - Semen Analysis for Overall Health12:50 - Daily Tadalafil and Its Benefits16:40 - Proactive Sexual Health Management21:28 - Female Sexual Health25:16 - Treating Delayed Ejaculation28:53 - Psychogenic Erectile Dysfunction31:16 - Technology in Sexual Health35:54 - Lifestyle Modifications for Better Sexual Health41:55 - Resources and Referrals for Patients44:30 - Final Thoughts

In this episode, recorded live at the 51st Academy Annual Meeting and Scientific Symposium in Atlanta, host Seth O'Brien, CP, FAAOP(D), explores the psychosocial impact of scoliosis with two leading voices in the field: Megan Glahn Castille, MS, CPO/LPO, assistant professor at Baylor College of Medicine and founder of the nonprofit Scolios-us, and David Speers, CPO/L, faculty member at Northwestern University Prosthetic Orthotic Center. They delve into strategies for easing patient anxiety, the power of empathy and encouragement, and how to foster patient empowerment. The conversation also covers current bracing options, educational practices, and helpful resources for clinicians and families navigating scoliosis care.  O&P Clinical Care Insiders is produced by Association Briefings.

Dr. Larry Lipshultz. is one of the world's leading experts in men's reproductive health. In this week's episode, we discuss testosterone therapy, male fertility, and the hidden environmental factors threatening men's health. Dr. Lipshultz shares groundbreaking insights into why male fertility is declining, common myths surrounding testosterone and prostate cancer, and innovative strategies to safely enhance men's reproductive and overall health.We cover: The alarming 50% drop in male fertility since the 1980s—and what's driving itTestosterone therapy myths: prostate cancer, fertility, and what's actually truePractical treatments for restoring fertility while on testosterone therapyAnabolic agents: risks, benefits, and smart usePersonalized, patient-centered care to optimize male reproductive and overall healthIf you care about men's health, fertility, or hormone optimization, this conversation is a must-listen.Who is Dr. Larry Lipshultz? Dr. Lipshultz's research focuses on male reproductive dysfunction, testosterone therapy, cardiovascular risk, and the genetics of infertility. He has pioneered innovations in testicular sperm extraction, vasectomy reversal, and testosterone optimization therapies. With over 460 peer-reviewed publications and as co-author of a foundational textbook on andrology, his contributions have significantly enhanced diagnostic approaches in male infertility. An early recipient of the American Urological Association Research Scholar award, he advocates for integrative andrologic health as a foundation for lifelong wellness.This episode is brought to you by: Puori - Get 20% off sitewide with Code DRLYON - https://Puori.com/DRLYONCozy Earth - Use code DRLYON for up to 40% off - https://cozyearth.comTimeline - Get 20% off your order of Mitopure - https://timeline.com/LYONManukora - Get $25 off the Starter Kit - https://manukora.com/DRLYONFind Dr. Lipshultz at: Website - https://www.larrylipshultz.com/Baylor College of Medicine - https://www.bcm.edu/people-search/larry-lipshultz-25437 LinkedIn - https://www.linkedin.com/in/larry-lipshultz-md-93977344/ Find Me At: Instagram:@drgabriellelyon TikTok: @drgabriellelyonFacebook: facebook.com/doctorgabriellelyonYouTube: youtube.com/@DrGabrielleLyonX (Twitter): x.com/drgabriellelyonApply to become a patient – https://drgabriellelyon.com/new-patient-inquiry/Join my weekly newsletter –

In this episode I speak with Cedric Dark MD MPH, an emergency medicine physician and healthcare policy expert, about gun violence in America. June is Gun Violence Awareness month. Our conversation focuses on prevention, advocacy, and content from his book Under the Gun: An ER Doctor's Cure for America's Gun Epidemic Cedric is an Associate Professor in the Henry J. N. Taub Department of Emergency Medicine at Baylor College of Medicine. He currently is on the Board of Trustees for Semester at Sea and is the Medical Editor-in-Chief for the monthly publication ACEP Now. From 2019 to 2024 he served on the Board of Directors for Doctors for America. Cedric argues that gun violence is a public health issue that healthcare workers are uniquely positioned to address. He explains how mental health factors into gun violence discussions and why access to firearms increases suicide risk. The conversation touches on how advocacy work can help healthcare workers deal with burnout and how organizations like Doctors for America approach health policy change.  If you enjoy the show, please leave a ⭐⭐⭐⭐⭐ rating on Apple or a

Developed by the Medical Student Membership Workgroup, the Urology Spotlight Series educates medical students about a particular subspecialty within urology, including common cases and procedures. In this episode, Daniela Orozco-Rendon, medical student at Geisel School of Medicine at Dartmouth, is joined by Dr. Mohit Khera, Professor of Urology and F. Brantley Scott Chair in Urology at Baylor College of Medicine, for a discussion on the field of Andrology/Men's Health.

How To Kick the Snooze Button Habit:Waking up several times interrupts and fragments sleep, which means you'll cycle back and forth between light, non restorative sleep and being awake, which isn't restful.It can leave you feeling tired and groggy when you finally get out of bed.It reinforces bad sleep habitsOn top of not feeling rested, alert and at your best, the sleep expert points out that consistently not getting enough sleep can raise the risk of weight gain, cardiovascular disorders, metabolic disorders and even dementia.Fortunately, you can break the sleep-snooze cycle by:Making sure you're getting enough sleep to feel truly rested, which is between seven and eight hours a night for most folks.Sticking to a consistent sleep schedule, which Auckley notes is easier if you time to rise to when your internal body clock starts to wake you up.In the morning, try to resist hitting snooze and get up as soon as your alarm goes off.Getting morning light exposure as soon as possible when you wake up, which helps keep your internal clock in sync and improves alertness.Have a positive morning ritual to look forward to, whether it's enjoying freshly made coffee on your porch or catching up on sports scores.Things You Are Still Wasting Your Money On:ATM FeesIn 2025, paying ATM fees is almost a fool's errand. With so many online banks offering free ATM withdrawals and brick-and-mortar banks offering a large network of free ATMs or ATM fee reimbursement, paying several dollars a month is seemingly avoidable. Simply put, there's no reason to waste money on fees just to access your own cash so even if it takes planning ahead, make sure you omit this expense.Bottled WaterShockingly, people continue to spend money on bottled water, even given both the financial and environmental downfalls. If you don't trust your tap water, even the cost of installing a filter or having one in your fridge can make it worth your money in the long run. Stop paying for something you can essentially get for free and invest in a quality reusable water bottle for when you're on the go.Brand-Name MedicationsUnless you're specifically advised by your doctor, opting for brand-name medications over their generic counterparts is a pointless expenditure. Generic drugs have the same active ingredients and undergo the same quality control as their branded counterparts. Switching to generics can save you hundreds or even thousands of dollars annually without compromising on health.Cable TV SubscriptionsThe world has moved on from traditional cable television, but many are still holding onto it — along with its hefty bill. Streaming services like Netflix, Hulu, and Disney+ offer customizable viewing options for a fraction of the price and even bundling options. If you're still paying for a bloated cable package, it's time to cut the cord and switch to more budget-friendly entertainment options.Extended WarrantiesRetailers love to upsell extended warranties, but the truth is, they're seldom worth it. Most products are built to last for at least the length of their original warranty, and by the time they break, chances are you'd be looking to upgrade anyway. Instead of shelling out for extended warranties, set aside a small emergency fund for when things really go wrong.Fast FashionCheap, trendy clothing may seem like a good deal, but fast fashion is a money pit. These clothes are usually poorly made and fall apart after just a few wears, forcing you to constantly replenish your wardrobe in a never-ending cycle for your closet and nearest landfill. Instead, invest in quality, timeless pieces that last longer. You'll not only save money but also reduce your environmental footprint.Premium Gas for Non-Luxury CarsUnless your car specifically requires premium gasoline, you're throwing money away by filling up with it, especially when gas prices are already so high. Modern engines are designed to run efficiently on regular unleaded gas, and using premium won't give you any added benefits in performance. Stick to regular gas and watch your fuel expenses drop in what you pay at the pump.Overpriced Online Shopping on AmazonName-brand phone chargers, headphones, and other items can cost up to three times as much on Amazon when compared to other retailers or the product's own website. Check reviews before you add something to your cart as many will let you know if it's worth the cost. Don't be afraid to shop around, as varying sticker prices could shock you.Unused Gym MembershipsIn 2025, no matter your fitness resolutions, there's no reason to pay for a gym membership you're not using. With the explosion of online workout platforms, free YouTube fitness channels, and affordable apps, staying in shape no longer requires an expensive gym pass, particularly if you don't go regularly. If you're still paying for a membership you rarely use, it's time to cancel and explore the world of free digital fitness.What ER Doctors Bring On Vacation:Anti-nausea medication - “Always pack Zofran, just in case,” said Dr. Cedric Dark, associate professor of emergency medicine at Baylor College of Medicine. “The feeling of nausea and vomiting is one of the most hated things you could ever imagine and there's nothing over-the-counter that is that helpful.” Zofran is only available by prescription, but it dissolves under your tongue, so it works even when you can't really keep anything down.A bug zapper - Dr. Dark says standalone mosquito traps or a mosquito zapper racquet like the one he uses are must-haves for traveling somewhere tropical, where the insects can carry serious diseases like West Nile virus, Zika virus and dengue fever.Tweezers - They're a fix for the far more simple, but common problem of splinters, and that's why tweezers are a travel essential for Dr. Joy Crook, associate professor of clinical emergency medicine at Vanderbilt University Medical Center.Compression socks - The CDC warns that traveling for more than four hours by air, car or bus raises the risk of developing blood clots, but wearing compression socks can help lower that risk. That's why they're a go-to for Dr. Erin Muckey, associate professor of emergency medicine at Rutgers New Jersey Medical School.A portable charger - Dr. Eric Adkins, an emergency medicine physician at the Ohio State University Wexner Medical Center, points out that you can't call for help or look up where the nearest pharmacy or hospital is with a dead phone battery, so he packs a portable charger.A carbon monoxide detector - Dr. Crook says this is a recent addition to her travel bag, since several stories of travelers dying from carbon monoxide poisoning have happened this year alone.Melatonin - Not sleeping well can weaken the immune system, which can make you more likely to get sick, but melatonin supplements can help “reset your internal clock,” according to Adkins, so you can snooze.Second Date Update: Dalia and Reggie go to the Mountain Winery to see Chris Isaak. She loved every minute. He has disappeared...was it her dancing?

Episode 192: ADHD Treatment.  Jordan Redden (MSIV) explains the treatment of ADHD. Dr. Bustamante adds input about pharmacologic and non-pharmacologic treatments. Dr. Arreaza shares the how stimulants were discovered as the treatment for ADHD. Written by Jordan Redden, MSIV, Ross University School of Medicine. Comments and edits by Isabelo Bustamante, MD, and Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction.ADHD is a chronic neurodevelopmental condition characterized by inattention, impulsivity, and/or hyperactivity. While it's often diagnosed in childhood, symptoms can persist well in adulthood. The treatment for ADHD is multifaceted. It often includes medication, behavioral therapy, environmental modifications, and sometimes educational interventions which are especially effective in younger patients. Ongoing evaluation is needed during treatment. Treatment needs adjustments over time.Starting with medications: Stimulants are the most well-studied and effective pharmacologic treatment for ADHD. These include methylphenidate-based medications such as Ritalin, Concerta, and Focalin, and amphetamine-based options, like Adderall, Vyvanse, and Dexedrine. Discovery of stimulants for ADHD> Dr. Charles Bradley discovered stimulants as the treatment for ADHD around 1937. ADHD did not have a name at that time, but it was known that some children had behavioral problems related to poor attention and inability to control their impulses, but they were still intelligent. Dr. Bradley was a psychiatrist who was working in the Bradley Hospital (Rhode Island), he was studying these children and, as part of his experiments, they developed severe headaches. He gave “Benzedrine” (a decongestant) to his pediatric patients to treat severe headaches, and he discovered that Benzedrine improved academic performance and interest in school and improved disruptive behavior in some children.How do stimulants work.Stimulants work primarily by increasing dopamine and norepinephrine levels in the brain, which helps improve focus, attention span, and impulse control. They typically show a rapid onset of action and can lead to noticeable improvements within the first few days of use. Dosing is individualized and should start low with gradual titration. Side effects can include reduced appetite, insomnia, headaches, increased heart rate, and emotional lability.Types of stimulants. Stimulants come as short acting and long acting. They can come as a tablet, liquid, patch, or orally disintegrating tablet. After the discovery of Benzedrine as a possible treatment for ADHD, more research was done over the years, and Ritalin became the first FDA-approved medication for ADHD (1955). The list of medications may seem overwhelming, but there are only two types of stimulants used to treat ADHD: methylphenidate and amphetamine. Long-acting stimulant medications are often preferred for their consistent symptom control and lower potential for misuse. Vyvanse (lis-dexa-mfetamine) is a widely used long-acting amphetamine-based option. As a prodrug, it remains inactive until metabolized in the body, which results in a smoother onset and offset of action and may reduce the risk of abuse. This extended duration of effect can help patients maintain focus and regulate impulses throughout the day without the peaks and crashes sometimes seen with shorter-acting formulations. Of note, Vyvanse is also approved for Binge Eating Disorder. Many of these medications are Schedule II controlled substances, so to prescribe them you need a DEA license. Other long-acting options include Concerta, an extended-release methylphenidate, as well as extended-release versions of Adderall and Focalin. These are especially helpful for school-aged children who benefit from once-daily dosing, and for adults who need sustained attention during work or academic activities. The choice between short- and long-acting stimulants depends on individual response, side effect tolerance, and daily routine.For patients who cannot tolerate stimulants, or for those with contraindications such as a history of substance misuse or certain cardiac conditions, non-stimulant medications are an alternative. One of the most used is atomoxetine, which inhibits the presynaptic norepinephrine transporter (NET). This leads to increased levels of norepinephrine (and to a lesser extent dopamine). Guanfacine or clonidine are alpha-2A adrenergic receptor agonists that lead to reduced sympathetic outflow and enhanced prefrontal cortical function, improving attention and impulse control. These alpha agonists are particularly useful in younger children with significant hyperactivity or sleep disturbances.Non-pharmacologic treatments.Behavioral therapy before age 6 is the first choice, after that, medications are more effective than BH only, and as adults again you use CBT.Medication is often just one part of a broader treatment plan. Behavioral therapy, especially in children, plays a critical role. Parent-training programs, positive reinforcement systems, and structured routines can significantly improve functioning. And for adolescents and adults, cognitive-behavioral therapy (CBT) is particularly helpful. CBT can address issues like procrastination, time management, emotional regulation, and self-esteem which are areas that medication doesn't always touch.Using medications for ADHD can be faced with resistance by parents, and even children. There is stigma and misconceptions about mental health, there may be concerns about side effects, fear of addiction, negative past experiences, and some parents prefer to treat ADHD the “natural” way without medications or only with supplements. All those concerns are valid. Starting a medication for ADHD is the first line of treatment in children who are 6 years and older, but it requires a shared decision with parents and patients. Cardiac side effects are possible with stimulants. EKG may be needed before starting stimulants, but it is not required. Get a personal and family cardiac history, including a solid ROS. Benefits include control of current condition and treating comorbid conditions.The presentation of ADHD changes as the person goes through different stages of life. For example, you may have severe hyperactivity in your school years, but that hyperactivity improves during adolescence and impulsivity worsens. It varies among sexes too. Women tend to present as inattentive, and men tend to be more hyperactive. ADHD is often underdiagnosed in adults, yet it can significantly impact job performance, relationships, and mental health. In adults, we often use long-acting stimulants to minimize the potential for misuse. And psychotherapy, particularly CBT or executive functioning coaching, can be life-changing when combined with pharmacologic treatment. There are several populations where treatment must be tailored carefully such as pregnant patients, individuals with co-occurring anxiety or depression, and those with a history of substance use. For example, atomoxetine may be preferred in patients with a history of substance misuse. And in children with coexisting oppositional defiant disorder, combined behavioral and pharmacologic therapy is usually more effective than either approach alone.Comorbid conditions.Depression and anxiety can be comorbid, and they can also mimic ADHD. Consult your DSM-5 to clarify what you are treating, ADHD vs depression/anxiety.Treatment goes beyond the clinic. For school-aged children, we often work closely with schools to implement 504 plans or Individualized Education Programs (IEPs) that provide classroom accommodations. Adults may also benefit from workplace strategies like structured schedules, noise-reducing headphones, or even coaching support. Ongoing monitoring is absolutely essential. We assess side effects of medication, adherence, and symptom control. ***In children, we also monitor growth and sleep patterns. We often use validated rating scales, like the Vanderbilt questionnaire for children 6–12 (collect answers from two settings) or Conners questionnaires (collect from clinician, parents and teachers), to track progress. And shared decision-making with patients and families is key throughout the treatment process.To summarize, ADHD is a chronic but manageable condition. Effective treatment usually involves a combination of medication and behavioral interventions, tailored to the individual's needs. And early diagnosis and treatment can significantly improve quality of life academically, socially, and emotionally.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text rev. (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022. CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder). Understanding ADHD. Accessed May 2025. https://chadd.org National Institute for Health and Care Excellence (NICE). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE guideline [NG87]. Updated March 2018. Accessed May 2025. https://www.nice.org.uk/guidance/ng87 Pliszka SR; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724 Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 Texas Children's Hospital. ADHD Provider Toolkit. Baylor College of Medicine. Accessed May 2025. https://www.bcm.edu Wolraich ML, Hagan JF Jr, Allan C, et al. Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis. UpToDate. Published 2024. Accessed May 2025.https://www.uptodate.comThe History of ADHD and Its Treatments, https://www.additudemag.com/history-of-adhd/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Markets fall as President Trump threatens to increase tariffs on Apple and the European Union. Former Chancellor of the University of North Carolina Chapel Hill Holden Thorp discusses his concerns over the Trump administration's attack on higher education. Baylor College of Medicine Dean Dr. Peter Hotez explains the new COVID-19 vaccine formula and guidance from the FDA. NBC News White House Correspondent Yamiche Alcindor reports on the reality of Trump's campaign promise to expand access to IVF.

Over 160 million Americans are served by Optum, yet many still don't fully understand what it actually does—or why it matters.Dr. Patrick Conway, newly appointed CEO of Optum and former head of CMS Innovation Center and Blue Cross NC, joins Steve for a wide-ranging discussion on the state of healthcare delivery, affordability, and the potential of value-based care at a national scale. With experience spanning the frontlines of medicine to top government and corporate leadership, Conway breaks down how Optum aims to improve care while controlling costs—and why he continues to practice as a pediatric hospitalist on weekends.We cover:

Dr. Margaret "Peggy" Goodell is the Vivian L. Smith Chair in Regenerative Medicine and Director of the Stem Cell and Regenerative Medicine Center at Baylor College of Medicine. Her research focuses on HSC regulation and aging. She talks about her discovery of a side population of HSCs, as well as her work on DNMT3A mutation and clonal hematopoiesis of indeterminate potential. Finally, she discusses the rich research environment in Houston.

Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Moussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncomplicated Type B Aortic Dissection (uTBAD). The IMPROVE-AD Trial is a multicenter randomized trial funded by the NIH/NHLBI that compares thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) vs. OMT and surveillance with selective TEVAR in patients with uncomplicated TBAD. The trial aims to address critical gaps in evidence left by prior studies (INSTEAD-XL, ADSORB), with a unique focus on quality of life, cost-effectiveness, and genetic data. Dr. Firas Mussa is a professor and the Chief of Vascular and Endovascular Surgery at McGovern Medical School at UTHealth Houston. He previously served as the Director of the Vascular Surgery Residency and Fellowship programs at NYU Langone Health. Dr. Mussa earned his medical degree from the University of Baghdad, followed by general surgery training at Johns Hopkins University and a vascular surgery fellowship at Baylor College of Medicine. His research focuses on complex aortic pathology, and he serves as the principal investigator of the IMPROVE AD trial. Mr. Jake Howitt is the Community Engagement Co-Chair of the IMPROVE AD trial and a leading patient advocate within the PCORI-funded Aortic Dissection Collaborative. As a survivor of aortic dissection, he is passionate about improving patient-provider communication and raising awareness of hereditary aortic disease. His work emphasizes the importance of education, empathy, and community-building in clinical research and care delivery. Special thank you to Jacob Soucy (@JacobWSoucy). Resources: ·       Treatment of Uncomplicated Type B Aortic Dissection: Optimal Medical Therapy vs TEVAR + Optimal Medical Therapy- https://journals.sagepub.com/doi/10.1177/15385744231184671?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed  ·       INSTEAD Trial - https://pubmed.ncbi.nlm.nih.gov/19996018/ ·       INSTEAD-XL 5-Year Follow-Up - https://pubmed.ncbi.nlm.nih.gov/23922146/ ·       ADSORB Trial - https://pubmed.ncbi.nlm.nih.gov/24962744/ ·       Feasibility of a proposed randomized trial in patients with uncomplicated descending thoracic aortic dissection: Results of worldwide survey - https://pubmed.ncbi.nlm.nih.gov/27823685/ ·       Treatment of AD: Meta-Analysis - https://pubmed.ncbi.nlm.nih.gov/29066151/ ·       TEVAR vs Medical Therapy- https://pubmed.ncbi.nlm.nih.gov/36334259/ ·       IMPROVE AD Trial website - https://improvead.org ·       John Ritter Foundation for Aortic Health - https://johnritterfoundation.org ·       Think Aorta US - https://thinkaorta.us   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.      

The CDC reported 12 seasonal flu-related deaths of children this week, bringing the total number of pediatric flu deaths this season to 216 — the most in 15 years. Experts say one reason for this new record could be the plummeting flu vaccination rate among American children. John Yang speaks with Dr. Peter Hotez at Baylor College of Medicine to learn more. PBS News is supported by - https://www.pbs.org/newshour/about/funders

In this episode of the Healthy, Wealthy, and Smart Podcast, host Karen Litzy welcomes Dr. Lilian O. Ebuoma, a Harvard-trained breast radiologist and author of "Love Your Breasts, Love Yourself." With over two decades of experience in health and wellness, Dr. Ebuoma shares her journey from joining the U.S. Navy at 19 to pursuing her passion for medicine inspired by her grandmother, a midwife in Nigeria. The discussion emphasizes the importance of breast health and provides insights into holistic breast care. Tune in to learn more about Dr. Ebuoma 's expertise and her comprehensive guide to nurturing breast health. Links to her book and additional resources are available in the show notes.   Time Stamps:  [00:01:25] Journey into healthcare and radiology. [00:06:21] Breast cancer mortality disparities. [00:10:40] Self-examination for breast health. [00:14:14] Mammography screening recommendations. [00:15:18] Breast density and screening. [00:20:46] Diagnostic mammogram process explained. [00:24:15] Emotional wellbeing and breast health. [00:27:14] Cultural stigma and breast cancer. [00:32:03] Emotional impact of cancer diagnosis. [00:34:39] Complementary therapies in oncology. [00:39:07] Breast awareness and self-care. [00:42:06] Love your breasts, love yourself.   More About Dr. Lilian O. Ebuoma: Dr. Lilian Ebuoma is a Harvard-trained breast radiologist, certified physician executive, social entrepreneur, U.S Navy Veteran, and certified professional coach. She has more than two decades of experience in the health and wellness industry, including in the United States Navy.  She is a Fellow of the Institute of Coaching at McLean, Harvard Medical School Affiliate, and a 2027 Fellow of the American College of Radiology. Dr. Ebuoma is the founder of Lilly Women's Health and Lilly Cares Foundation (LCF) in Lagos, Nigeria with a primary focus of streamlining breast care to improve breast cancer morbidity and mortality outcomes in underserved areas.  A former Associate Professor of radiology, she has authored multiple scientific publications with a focus on breast health. She also is the Executive Producer of Tufiakwa: Witnessing the Breast Cancer Journey and author of Love Your Breasts, Love Yourself.  The recipient of the Navy and Marine Corps Achievement Medal and Early Faculty Excellence Award from the Baylor College of Medicine, Dr. Ebuoma was named top 50 most influential women in Nigeria by Business Day in 2023.  Resources from this Episode: Love Your Breasts Love Yourself Book Dr. Ebuoma's Website Dr. Ebuoma on Instagram Dr. Ebuoma on LinkedIn   Jane Sponsorship Information: Book a one-on-one demo here Front Desk @ Jane Mention the code LITZY1MO for a free month   Follow Dr. Karen Litzy on Social Media: Karen's Twitter Karen's Instagram Karen's LinkedIn   Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio

Thinking about doing an away rotation? In this episode of Behind the Knife, we break down everything you need to know about away rotations and sub-internships. From how to apply and what to expect to making a great impression and building connections, we've got you covered. Plus, we discuss whether you should even do an away rotation at all and how to decide if it's the right move for your application. We're joined by a fantastic and diverse group of general surgery residents who share their insights, tips, and experiences. Episode Hosts: –Dr. Josh Roshal, University of Texas Medical Branch, @Joshua_Roshal, jaroshal@utmb.edu –Dr. Colleen McDermott, University of Utah, @ColleenMcDMD, Colleen.McDermott@hsc.utah.edu –Dr. Sophia Williams-Perez, Baylor College of Medicine, @SophWPerez, Sophia.Williams-Perez@bcm.edu –CoSEF: @surgedfellows, cosef.org Guests:  Dr. Steven Thornton, Duke University Medical Center, @swthorntonjr swt12@duke.edu Dr. Nicole Santucci, Washing University in St. Louis, @nicolemsantucci  snicole@wustl.edu Abbas Karim, MS3, University of Texas Medical Branch, @_AbbasKarim aakarim@utmb.edu Reagan Collins, MS4, Texas Tech University Health Sciences Center, @ReaganACollins, reagan.collins@ttuhsc.edu Dr. Annie Hierl, Indiana University, @annie_hierl ahierl@iu.edu  Dr. Jorge Zarate Rodriguez, Washington University in St Louis, @jzaraterod, j.zarate@wustl.edu  References: McDermott CE, Anand A, Brian R, Gan C, L'Huillier JC, Lund S, Sathe T, Silvestri C, Woodward JM. Should I Do a General Surgery Away Rotation?: Perspectives From the Collaboration of Surgical Education Research Fellows (CoSEF). Ann Surg Open. 2024 Dec 3;5(4):e509. doi: 10.1097/AS9.0000000000000509. PMID: 39711667; PMCID: PMC11661735. https://pubmed.ncbi.nlm.nih.gov/39711667/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.